Robot Assisted Retroperitoneal Lymph Node Dissection (RPLND)

Robot Assisted Retroperitoneal Lymph Node Dissection (RPLND) is an advanced surgical technique primarily used in the treatment of testicular cancer, particularly when the cancer has spread to the retroperitoneal lymph nodes. This procedure involves the removal of lymph nodes from the area behind the abdominal cavity, known as the retroperitoneum, where cancer may have spread from the testicles. The use of robotic assistance enhances the precision and accuracy of the surgery, allowing surgeons to perform the procedure through smaller incisions, which reduces trauma to surrounding tissues. The robotic system offers high-definition 3D visualization, providing surgeons with a clearer view of critical structures and allowing for greater control during the dissection of lymph nodes. This leads to a reduction in complications, including damage to surrounding organs, and contributes to faster recovery times when compared to traditional open surgery.

Benefits and Recovery After Robot Assisted RPLND

The benefits of Robot Assisted Retroperitoneal Lymph Node Dissection are numerous, particularly in terms of patient recovery and surgical outcomes. As a minimally invasive procedure, RPLND performed with robotic assistance results in smaller incisions, less postoperative pain, and a quicker recovery. Many patients can expect to return home within a few days and resume normal activities within a few weeks, with minimal disruption to their daily lives. The enhanced precision of the robotic system also helps preserve important nearby structures, such as blood vessels and nerves, which can lead to better functional outcomes. Additionally, patients typically experience fewer complications, such as infection or blood loss, making the procedure a safer option. Despite the complexity of the surgery, robot-assisted RPLND offers a high level of accuracy, ensuring thorough removal of the cancerous lymph nodes while maintaining a faster and more comfortable recovery for patients dealing with testicular cancer.

120K +

HAPPY PATIENTS

200

SPECIALIST DOCTORS

30+

MEDICAL SERVICES

150K

PROBLEM SOLVE